EyePoint (EYPT) Other Non Operating Income (2010 - 2026)
EyePoint (EYPT) reported Other Non Operating Income of $2.3 million for Q1 2026, down 35.64% on a YoY basis from $3.6 million in Q1 2025, and down 19.78% sequentially from $2.9 million in Q4 2025.
EyePoint (EYPT) Other Non Operating Income (2010 - 2026) Analysis & Trends
EyePoint (EYPT) has 17 years of Other Non Operating Income data on file, last reported at $2.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income fell 35.64% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $10.5 million (down 28.86% YoY), and the FY2025 full-year result was $11.8 million, down 22.12% from the prior year.
- Other Non Operating Income declined to $2.3 million in Q1 2026, from $2.9 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $4.0 million in Q1 2024 to a low of -$2.6 million in Q4 2022.
- A 5-year average of $1.9 million and a median of $2.3 million in 2023 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 10566.67% in 2022, while the deepest fall reached 156000.0% in 2022.
- Tracing EYPT's Other Non Operating Income over 5 years: stood at -$2.6 million in 2022, then jumped by 189.03% to $2.3 million in 2023, then soared by 68.69% to $3.9 million in 2024, then retreated by 25.91% to $2.9 million in 2025, then slipped by 19.78% to $2.3 million in 2026.
- Business Quant data shows EYPT's Other Non Operating Income at $2.3 million in Q1 2026, $2.9 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.34 Mn |
| Dec 31, 2025 | 2.92 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | 3.64 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 3.39 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 4.04 Mn |
| Dec 31, 2023 | 2.34 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | -1.35 Mn |
| Mar 31, 2023 | 1.20 Mn |
| Dec 31, 2022 | -2.63 Mn |
| Sep 30, 2022 | 640,000.00 |
| Mar 31, 2022 | -1.56 Mn |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 280,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | -905,000.00 |